BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $197,000 | -85.7% | 3,200 | -86.6% | 0.01% | -86.3% |
| Q2 2022 | $1,375,000 | +66.7% | 23,900 | -45.6% | 0.10% | +115.9% |
| Q1 2022 | $825,000 | +47.8% | 43,904 | +69.5% | 0.04% | +83.3% |
| Q4 2021 | $558,000 | +272.0% | 25,908 | +2073.5% | 0.02% | +242.9% |
| Q3 2021 | $150,000 | +2900.0% | 1,192 | +496.0% | 0.01% | – |
| Q2 2021 | $5,000 | -95.9% | 200 | -97.2% | 0.00% | -100.0% |
| Q1 2021 | $122,000 | -83.3% | 7,069 | -82.6% | 0.01% | -82.9% |
| Q4 2020 | $729,000 | +185.9% | 40,612 | +29.1% | 0.04% | +118.8% |
| Q3 2020 | $255,000 | -32.4% | 31,465 | +0.8% | 0.02% | -33.3% |
| Q2 2020 | $377,000 | +57.1% | 31,200 | +236.9% | 0.02% | +100.0% |
| Q1 2020 | $240,000 | -55.3% | 9,262 | -54.9% | 0.01% | -63.6% |
| Q4 2019 | $537,000 | +5.3% | 20,551 | -24.3% | 0.03% | -28.3% |
| Q3 2019 | $510,000 | -34.7% | 27,142 | -26.3% | 0.05% | -36.1% |
| Q2 2019 | $781,000 | +2903.8% | 36,826 | +557.6% | 0.07% | +2300.0% |
| Q1 2019 | $26,000 | +766.7% | 5,600 | +409.1% | 0.00% | – |
| Q3 2018 | $3,000 | -75.0% | 1,100 | -15.4% | 0.00% | -100.0% |
| Q2 2018 | $12,000 | -91.5% | 1,300 | -94.1% | 0.00% | -91.7% |
| Q1 2018 | $142,000 | – | 22,059 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |